HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 22 filers reported holding HEPION PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $23,000 | -95.9% | 20,479 | -93.3% | 0.00% | -97.3% |
| Q1 2021 | $564,000 | +216.9% | 306,338 | +434.5% | 0.11% | +307.4% |
| Q3 2020 | $178,000 | +39.1% | 57,309 | -21.0% | 0.03% | -49.1% |
| Q1 2020 | $128,000 | -54.0% | 72,575 | -36.9% | 0.05% | -64.7% |
| Q3 2019 | $278,000 | – | 115,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 51,989 | $79,543,000 | 0.24% |
| ASSET MANAGEMENT CORP /IL/ /ADV | 133,500 | $204,000 | 0.10% |
| Ikarian Capital, LLC | 553,273 | $847,000 | 0.06% |
| McAdam, LLC | 55,978 | $86,000 | 0.01% |
| JGP Wealth Management, LLC | 15,000 | $23,000 | 0.01% |
| Prospera Financial Services Inc | 30,300 | $46,000 | 0.00% |
| Fort Point Capital Partners LLC | 10,000 | $15,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 55,599 | $85,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 6,501 | $10,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 49,800 | $76,000 | 0.00% |